What is Clinc?
Headquartered in Ann Arbor, Michigan, and established in 2015, Clinc operates at the forefront of artificial intelligence, focusing on developing conversational AI that emulates human intelligence. The company's technology aims to revolutionize how businesses interact with their customers through advanced AI-driven dialogue systems. Clinc's strategic positioning in the AI market, particularly in conversational interfaces, highlights its potential to disrupt various industries by enhancing user engagement and operational efficiency. The company's journey, marked by consistent capital raises, indicates a strong investor confidence in its technological capabilities and market vision.
How much funding has Clinc raised?
Clinc has raised a total of $59.8M across 4 funding rounds:
Other Financing Round
$250K
Unspecified
$1.2M
Series A
$6.3M
Series B
$52M
Other Financing Round (2015): $250K with participation from elab Ventures
Unspecified (2016): $1.2M led by eLab Ventures and Hyde Park Venture Partners
Series A (2017): $6.3M supported by Hyde Park Venture Partners and Drive Capital
Series B (2019): $52M featuring Drive Capital, Hyde Park Venture Partners, Draper Associates, and Insight Partners
Key Investors in Clinc
Hyde Park Venture Partners
Hyde Park Venture Partners is an early-stage venture capital firm that focuses on high-growth technology startups located in the mid-continent region. They seek to invest in companies with exceptional founding teams and significant growth potential, typically during their first or second round of capital raising.
Drive Capital
Drive Capital is a venture capital firm based in Columbus that invests in exceptional founders creating the next generation of market-defining companies. The firm focuses on providing capital and support to entrepreneurs across various industries, emphasizing partnerships that drive growth from idea to IPO.
Draper Associates
Draper Fisher Jurvetson is a leading venture capital firm with a global presence through a network of affiliated funds. DFJ's mission is to identify, serve and provide capital for extraordinary entrepreneurs anywhere who are determined to change the world.
What's next for Clinc?
With its recent major strategic investment, Clinc is poised for an accelerated growth phase. The company is likely to leverage this capital to enhance its AI platform, expand its research and development efforts, and broaden its market reach. Future strategic initiatives may include forging new partnerships, entering untapped markets, and further refining its AI algorithms to maintain a competitive edge. The ongoing commitment from investors suggests a clear trajectory towards scaling operations and solidifying its position as a leader in the conversational AI sector.
See full Clinc company page